Abstract:Modic changes are radiographic features associated with microfracture, low-virulence organism infection and chronic inflammation with inflammatory cell infiltration in the vertebral endplate region. Mast cells, as innate immune cells similar to macrophages, are present in painful degenerated intervertebral discs. However, the involvement and mechanisms of mast cells in the development of Modic changes remain unclear. Herein, we found increased mast cell infiltration in samples from patients with Modic changes and in mouse models of Modic changes. To clarify the role of mast cells in the progression of Modic changes, we used mast cell-deficient (KITW-SH/W-SH) mice to construct a model of Modic changes and found that the severity of Modic changes in KITW-SH/W-SH mice was significantly lower than that in WT mice. These findings were further supported by the use of a mast cell-specific activator (compound 48/80) and a stabilizer (cromolyn). Furthermore, we found that mast cells were not activated via the classic IgE pathway in the Modic change models and that Mrgprb2 is the specific receptor for mast cell activation reported in recent studies. Then, we utilized Mrgprb2 knockout mice to demonstrate that Mrgprb2 knockout inhibited mast cell activation and thus reduced the degree of Modic changes. Transcriptomic sequencing revealed aberrant PI3K-AKT and MAPK pathway activation in the Mrgprb2-deficient mast cells. Additionally, Mrgpbrb2-activated mast cells regulate immune niches by recruiting macrophages, promoting M1 polarization and reducing M2 polarization, thereby promoting the progression of Modic changes. These findings suggest that mast cells may serve as a novel therapeutic target for addressing Modic changes. Degenerative disorders of the lower back are common and can greatly affect life quality. The research by Ji et al. examines the role of mast cells (a kind of immune cell) in the development of these disorders. They discovered that mast cells aid in the progression of Modic changes (a type of spinal degeneration), by affecting the metabolism of the endplates (the ends of the spinal bones) and altering the immune response. This was shown through experiments with human tissue samples, animal models, and cell studies. The results suggest that focusing on mast cells could be a potential treatment for Modic changes. The research also emphasizes the significance of the Mrgprb2 receptor (a protein that activates mast cells) as a potential drug target. "This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author."

Role of brain mast cell in multiple sclerosis and Wernicke's encephalopathy]

Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis

Role and mechanisms of mast cells in brain disorders

Mrgprb2-mediated Mast Cell Activation Exacerbates Modic Changes by Regulating Immune Niches

Bidirectional effects of central mast cells on the nervous system

Minimally invasive vagus nerve stimulation modulates mast cell degranulation via the microbiota-gut-brain axis to ameliorate blood-brain barrier and intestinal barrier damage following ischemic stroke

The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis

Contribution of Dysregulated B-Cells and IgE Antibody Responses to Multiple Sclerosis

Microglia and Multiple Sclerosis

The Mast Cell Is an Early Activator of Lipopolysaccharide-Induced Neuroinflammation and Blood-Brain Barrier Dysfunction in the Hippocampus

Progress of Researches on the Mechanism of the Role of Nonspecific Inflammation Mediatedby Microglia Activation in the White Matter Demyelination of Vascular Cognitive Impairment

Mast Cell Activation in Brain Injury, Stress, and Post-traumatic Stress Disorder and Alzheimer's Disease Pathogenesis

Chemokines and Chemokine Receptors in Multiple Sclerosis

miRNAs Participate in MS Pathological Processes and Its Therapeutic Response.

Mast Cell: A Multi-Functional Master Cell

The Immune Pathogenesis of Multiple Sclerosis

Autophagy Modulation in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.

Relationship between T Cell Subsets and Pathogenesis of Multiple Sclerosis

Mast cell-mediated immune regulation in health and disease

Mast cell activation mediates blood–brain barrier impairment and cognitive dysfunction in septic mice in a histamine-dependent pathway

Mirnas Participate in MS Pathological Processes and Its Therapeutic Response